Showing results (401-410 of 1,378) with videos related to
Sort By:
Pageof 138
Hormones and Behavior|May 21, 2010
Sex-specificity in transgenerational epigenetic programmingGregory A Dunn, Christopher P Morgan, Tracy L BaleThe American Journal of Drug and Alcohol Abuse|January 1, 1988
Illicit methamphetamine: analysis, synthesis, and availabilityK S Puder, D V Kagan, J P MorganMedicine and Science in Sports and Exercise|January 1, 1982
A rat model of psychopathology for use in exercise scienceW P Morgan, E B Olson, N P PedersenJournal of the American Geriatrics Society|September 1, 1983
A survey of generic drug legislation and geriatric pharmacotherapy: opinions of those who generate the literatureJ P Morgan, L L Schwartz, F T ShermanClinical and Experimental Immunology|January 13, 2000
Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59M Mizuno, K Nishikawa, B P Morgan, et al.American Industrial Hygiene Association Journal|August 27, 1999
Prediction of respiratory distress during maximal physical exercise: the role of trait anxietyJ R Wilson, P B Raven, W P MorganBiochemical and Biophysical Research Communications|September 24, 1996
Simultaneous measurement of intracellular calcium and ventricular function in the phospholamban-deficient mouse heartT G Hampton, E G Kranias, J P MorganImmunology|November 1, 1994
Altered glycosylation and selected mutation in recombinant human complement component C9: effects on haemolytic activityK M Taylor, B P Morgan, A K CampbellLancet (London, England)|August 4, 1984
Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosisB P Morgan, A K Campbell, D A CompstonJournal of Immunology (Baltimore, Md. : 1950)|January 1, 1987
Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosisB P Morgan, J R Dankert, A F EsserPageof 138